Skip to main content

Table 1 Sequentially located forward strand native genes of human chromosome 1 q arm locus 22 in reference to LMNA within intergene loop tropy segments with nano-compliance of the same with respect to the gene

From: Anglemetry of neural axis cell differentiation genes by structural pressurotopy of DNA loop strand segment tropy in reference to tissue macro-compliance

 

Germline gene locusa

Episode category

(sub-episode block structure)b, c

Gene locus start and end base location

(no of locus bases;

Σ intergene base segment tropy)

Sequential integration (∫) to final esebssiwaagoTQ (fract)d

Final uppesebssiwaa, dppesebssiwaa

Peff esebssiwaagoTQ (fract)e

-12

DAP3, death associated protein 3

2 A 5

5′-155,687,960 – 155,739,010

(51,051; 3.09108E + 05)

0.093, 0.157, 0.210, 0.247

1.1196E + 04,

4.7835E + 04

0.234

-11

MSTO2P, misato family member, pseudogene

3 M 7

155,745,768 – 155,750,688

(4,921; 5.94486E + 05)

0.680, 0.417, 0.358, 0.340, 0.309, 0.269

1.8354E + 04,

6.7448E + 04

0.272

-10

PIR32612

3 A 7

155,750,710 – 155,750,759

(30;

5.26775E + 05)

0.0002, 0.242, 0.282, 0.218, 0.232, 0.224

1.3367E + 04,

5.8380E + 04

0.229

-9

LOC100132108

3 A 7

155,845,340 – 155,847,270

(1,931; 5.82948E + 05)

0.262, 0.357, 0.258, 0.198, 0.225, 0.205

1.4504E + 04,

6.8778E + 04

0.211

-8

SYT11, synaptotagmin 11

2 A 5

155,859,469 –

155,885,199

(25,731; 4.15371E + 05)

0.166, 0.401, 0.333, 0.266

1.8089E + 04,

6.7250E + 04

0.269

iiii-7

GC01P155896

3 A 7 (+ 1)

ACM

155,894,280 – 155,894,386

(107; 1.201927E+ 06)

0.188, 0.330, 0.205, 0.198, 0.144, 0.138, 0.131

1.8900E + 04,

1.31341E + 05

0.144

-6

lnc-RXFP4–5

3 M 7 (− 2)

NCA

155,934,457 – 155,936,536

(2,080; 5.72477E + 05)

0.335, 0.274, 0.292, 0.233, 0.314, 0.272, 0.250

2.6779E + 04,

8.5304E + 04

0.314

-5

RXFP4, relaxin family peptide//INSL5 receptor 4

3 A 7

155,941,689 – 155,942,949

(1,261; 4.25027E + 05)

0.144, 0.453, 0.451, 0.376, 0.299, 0.260

1.2920E + 04,

4.8207E + 04

0.268

-4

lnc-RXFP4–2

(ENSG00000273002)

3 M 7

155,978,659 – 155,983,018

(4,380; 1.210734E+ 06)

0.551, 0.184, 0.225, 0.208, 0.199, 0.162

2.7911E + 04,

1.58180E + 05

0.176

-3

ENSG00000224276/

LOC105371729

2 M 5

155,991,390 – 156,033,225

(41,836; 3.67426E + 05)

0.527, 0.209, 0.211, 0.236, 0.260, 0.247

1.4498E + 04,

5.5694E + 04

0.260

-2

GC01P156042 (LAMTOR2, late endosomal/lysosomal adaptor, MAPK and MTOR activator 2)

2 M 5 (−2)

NCA

156,042,571 – 156,060,811

(18,241; 2.91985E + 05)

0.358, 0.278, 0.259, 0.273

1.3666E + 04,

5.2795E + 04

0.259

-1

RAB25, member RAS oncogene family

3 A 7 (−2)

ACM

156,061,160 – 156,070,514

(9,355; 6.29741E + 05)

0.030, 0.356, 0.297, 0.434, 0.270, 0.242, 0.233

2.6153E + 04,

9.7028E + 04

0.270

 

LMNA, prelamin-A/C

2 A 5

156,082,156 – 156,140,089

(57,934; 9.51609E + 05)

0.156, 0.206, 0.162, 0.240

2.8948E + 04,

1.57549E + 04

0.184

1

SEMA4A, semaphorin 4A

2 M 5

156,147,359 – 156,177,752

(30,394; 2.95365E + 05)

0.449, 0.170, 0.173, 0.136

7.891E + 03,

5.8332E + 04

0.135

2

SLC25A44, solute carrier family 25 member 44

2 A 5

156,193,932 – 156,212,796

(18,865; 3.62292E + 05)

0.184, 0.226, 0.268, 0.399, 0.395, 0.378, 0.270

2.1658E + 04,

5.4827E + 04

0.395

3

PMF1-BGLAP, PMF1 (polyamine modulated factor 1)-BGLAP (bone gamma-carboxyglutamate protein) readthrough

2 A 5

156,212,982 – 156,243,332

(27,090; 3.92203E + 05)

0.005, 0.230, 0.161, 0.133

9.594E + 03,

6.5791E + 04

0.146

4

TMEM79, transmembrane Protein 79

3 A 7 (+1) ACM

156,282,913 – 156,293,185

(10,273; 1.848556E + 06)

0.335, 0167, 0.208, 0.194, 0.247, 0.245, 0.228

4.0434E + 04,

1.90636E + 05

0.212

5

TSACC, TSSK6 activating cochaperone

3 A 7

156,337,314 –

156, 346,395

(9,682; 7.43872E + 05)

0.028, 0.250, 0.327, 0.340, 0.364, 0.318

2.7118E + 04,

8.0818E + 04

0.336

6

RHBG, Rh family B glycoprotein

2 M 5

156,366,043 – 156,385,234

(19,192; 6.05950E + 05)

0.419, 0.280, 0.315, 0.302

2.6125E + 04,

9.1097E + 04

0.287

7

ENSG00000237390

3 A 7

156,388,226 – 156,395,609

(7,384; 9.58633E + 05)

0.020, 0.110, 0.164, 0.154, 0.137, 0.144

1.7374E + 04,

1.13726E + 05

0.153

8

lnc-TTC24–5

3 M 7

156,500,997 –

156,502,475

(1,479; 9.02656E + 05)

0.369, 0.321, 0.355, 0.242, 0.267, 0.290

4.1211E + 04,

9.6908E + 04

0.283

9

lnc-TTC24–4

3 A 7 (+2)

ACM

156,503,086 – 156,503,834

(749;

1.138955E + 05)

0.055, 0.276, 0.152, 0.193, 0.223, 0.235, 0.194

2.3007E + 04,

1.19362E + 05

0.193

10

lnc-TTC24–1

3 M 7

156,509,584 –

156,513,960

(4,377; 4.86984E + 05)

0.544, 0.097, 0.267, 0.342, 0.312, 0.264

1.4861E + 04,

5.5298E + 04

0.269

11

GC01P156524

3 A 7 (+ 2) ACM

156,524,535 – 156,525,810

(476;

1.492171E + 06)

0.141, 0.225, 0.162, 0.212, 0.223, 0.217, 0.232, 0.217, 0.199, 0.196, 0.205

2.6686E + 04,

1.34141E + 053 A 7

0.199

12

TTC24, tetratricopeptide repeat domain 24

3 M 7

156,579,727 – 156,587,797

(8,071; 8.54954E + 05)

0.406, 0.197, 0.184, 0.116, 0.145, 0.159

1.6633E + 04, 1.14108E + 05

0.146

13

NAXE, NAD(P) HX epimerase

3 A 7

156,591,762 – 156,594,299

(2,538; 1.422774E + 06)

0.125, 0.218, 0.153, 0.144, 0.159, 0.187

2.7892E + 04, 1.61601E + 05

0.190

14

HAPLN2, hyaluronan and proteoglycan link protein 2

3 M 7

156,618, 801–3 M 7 156,625,725

(6,925; 7.92243E + 05)

0.636 0.505, 0.456, 0.243, 0.209, 0.211, 0.188, 0.209, 0.194

1.8695E + 04,

9.9190E + 04

0.188

15

BCAN, brevican

2 M 5

156,641,390 – 156,659,532–3′

(18,143; 7.28923E + 05)

0.389, 0.212, 0.235, 0.262

2.7104E + 04,

1.11335E + 05

0.243

  1. a) RNA genes included are protein encoding genes, non-coding GC_, PIR_, ENSG_ and long non-coding lnc- naming convention mRNA genes including functional pseudogenes; b) Gene loci episodic structure sub-episode block categories include Episode 2 (> 11,864 ≤ 265,005 bases; 5 SEB), Episode 3 (≤ 11,864; 7 SEB), Episode 4 (>265,005 < 607,463; 9 SEB), Episode 5 (≥ 607,463 < 2,242,933; 11 SEB) or Episode 6 (≥ 2,242,933; 13 SEB); c) Gene loci sub-episode block structure variations include non-contributory anisotropy (NCA), anisotropy converted to mesotropy (ACM), and/or 0.5-factor adjusted stabilizing mesotropy or anisotropy converted to stabilizing isotropy for anisotropy or mesotropy (stIAfM, stIMfA or stIMfM) that result in initial to final SEB conversion; d) Integration is in underlined italics where the sequential sub-episode block structure is deviation from constancy (DfC) [25], as in the cases of gene locuses MSTO2P (pos − 11), lnc-RXFP4–5 (pos −6), ENSG00000224276 / LOC105371729 (pos −3), GC01P156042 (pos − 2), RAB25 (pos − 1), SLC25A44 (pos + 2), GC01P156524 (pos + 11) and HALPN2 (pos + 14); and e) Peff esebssiwaagoTQ is in italics where three (3) or more anisotropic or mesotropic genes are situated in tandem within the intergene tropy of the same in reference to LMNA located in native configuration
Back to article page